Company intelligence / Profile preview

Acutus Medical, Inc.

Carlsbad, California, United Statesacutusmedical.com ↗

Ownership: Public · AFIB
Development stage: Commercial

Overview

Acutus Medical has commercially available products including the AcQMap system and AcQCross Qx system. The company completed enrollment in the AcQForce Flutter IDE clinical trial for its AcQBlate FORCE sensing ablation system in May 2022, with final patient follow-up anticipated in June 2022 and subsequent PMA submission. The company is also developing pulsed field ablation (PFA) technology, which has shown promising pre-clinical results.

Therapeutic areas: Cardiovascular
Modalities: Cardiac Mapping SystemsAblation CathetersLeft-Heart Access Products
Industry: Therapeutic Medical Devices

Partnerships

Medtronic (sold left-heart access portfolio to)

Financials

Market cap: $3K
Total revenue: $7.1M
Enterprise value: $21.7M

Beyond the preview

Go deeper on Acutus Medical, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acutus Medical, Inc..

Explore the full profile